Scandinavian Journal of Pain
Volume 1, Issue 3 , Pages 120-121, July 2010

Long-term low-dose transdermal buprenorphine therapy for chronic noncancer pain

  • Petter C. Borchgrevink

      Affiliations

    • Department of Pain and Complex Disorders, St. Olav University Hospital, Trondheim, Norway
    • Pain and Palliation Research Group, Department of Circulation and Medical Imaging, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway
    • Corresponding Author InformationCorrespondence address: Department of Pain and Complex Disorders, St. Olav University Hospital, Trondheim, Norway.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1877-8860(10)00081-9

doi:10.1016/j.sjpain.2010.05.034

Refers to corrigendum:

  • Corrigendum to “A 6-months, randomised, placebo-controlled evaluation of efficacy and tolerability of 7 day buprenorphine transdermal patch in osteoarthritis patients naïve to potent-opioids” [Scandinavian Journal of Pain 1 (2010) 122–141]

    Harald Breivik, Tone Marte Ljosaa, Kristian Stengaard-Pedersen, Jan Persson, Hannu Aro, John Villumsen, Dorthe Tvinnemose
    Scandinavian Journal of Pain October 2010 (Vol. 1, Issue 4, Page 235)

Scandinavian Journal of Pain
Volume 1, Issue 3 , Pages 120-121, July 2010

Article Tools